Literature DB >> 950588

Comparative bioavailability: eight commercial prednisone tablets.

T J Sullivan, M R Hallmark, E Sakmar, D J Weidler, R H Earhart, J G Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 950588     DOI： 10.1007/bf01086151

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  9 in total

1.  In vitro and in vivo availability of commercial prednisone tablets.

Authors:  T J Sullivan; E Sakmar; K S Albert; D C Blair; J G Wagner
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

2.  Bioavailability and pharmacokinetics of prednisone in humans.

Authors:  A R Disanto; K A Desante
Journal:  J Pharm Sci       Date:  1975-01       Impact factor: 3.534

3.  Inactive prednisone tablets U.S.P. XVI.

Authors:  F A CAMPAGNA; G CURETON; R A MIRIGIAN; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

4.  DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS.

Authors:  T NICHOLS; C A NUGENT; F H TYLER
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

5.  Urinary metabolic products of prednisone and prednisolone.

Authors:  C H GRAY; M A GREEN; N J HOLNESS; J B LUNNON
Journal:  J Endocrinol       Date:  1956-10       Impact factor: 4.286

6.  Radioimmunoassay for prednisolone.

Authors:  W A Colburn; R H Buller
Journal:  Steroids       Date:  1973-06       Impact factor: 2.668

7.  Radioimmunoassay for prednisone.

Authors:  W A Colburn
Journal:  Steroids       Date:  1974-07       Impact factor: 2.668

8.  Conversion of cortisone to cortisol and prednisone to prednisolone.

Authors:  J S Jenkins; P A Sampson
Journal:  Br Med J       Date:  1967-04-22

9.  Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.

Authors:  L W Powell; E Axelsen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059
  9 in total
  5 in total

1.  Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Authors:  J G Wagner; D A Ganes; K K Midha; I Gonzalez-Younes; J C Sackellares; L D Olson; M B Affrime; J E Patrick
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

2.  Comparative bioavailability: a new type of in vitro--in vivo correlation exemplified by prednisone.

Authors:  T J Sullivan; E Sakmar; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

3.  Plasma protein binding of prednisolone in normal volunteers and arthritic patients.

Authors:  I T Ağabeyoğlu; R F Bergstrom; W R Gillespie; J G Wagner; D R Kay
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

Review 4.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

5.  Dose dependent pharmacokinetics of prednisone and prednisolone in man.

Authors:  J Q Rose; A M Yurchak; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1981-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.